Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation on Mounjaro is common, and usually temporary. Tirzepatide slows the movement of food through your digestive system, which means your gut has more time to absorb water from stools — the very mechanism that causes constipation for a significant number of people starting or increasing their dose. It is a prescription-only medicine, so any changes to how you manage side effects should be discussed with your prescriber. Most people find the discomfort settles within a few weeks, and there are practical steps that genuinely help in the meantime.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether constipation is a sign that something has gone badly wrong. It isn't. It is one of the most predictable responses to a medicine that deliberately slows gastric emptying. Tirzepatide activates both GIP and GLP-1 receptors, which reduces appetite and helps regulate blood sugar, but that same slowing of digestion also gives the large intestine more time to pull water from whatever is passing through. The result, for many people, is harder, less frequent stools.
The NHS medicines page for tirzepatide lists constipation as a common side effect. It appeared in the SURMOUNT-1 trial data alongside the more talked-about nausea. Importantly, it does not indicate that the medicine is failing you, that your dose is wrong, or that you need to stop. It is biology doing exactly what the pharmacology predicts.
Where constipation does become a concern is when it arrives alongside severe stomach pain, particularly pain that spreads toward the back. That pattern can point to something other than ordinary sluggish digestion, and it needs same-day medical assessment. More on that below.
If you sailed through the 2.5 mg starting period and then hit a wall of constipation at 5 mg or beyond, you are not unusual. Each step up the dosing schedule intensifies the gut-slowing effect, at least temporarily. Your digestive system has to recalibrate, and that process takes time, often one to three weeks, though it varies considerably between people.
Hydration matters more than people realise at this point. When your gut moves more slowly, drinking enough water is the single most effective buffer against hard stools. Many people on tirzepatide also eat considerably less than before, which can mean less fibre if they are not paying attention to what they do eat. Protein tends to crowd out vegetables in smaller meals; keeping some soluble fibre in (oats, lentils, cooked vegetables) makes a real difference.
Gentle physical activity helps too. Even a short walk after eating stimulates gut motility in ways that sitting still does not. If constipation is severe or prolonged, your prescriber may suggest an over-the-counter osmotic laxative; do not assume any laxative is fine without checking, as stimulant laxatives in particular are not always appropriate alongside GLP-1 medicines. Our detailed guide to constipation on Mounjaro covers practical management options in full.
Ordinary constipation on tirzepatide is uncomfortable but not dangerous. There are specific symptoms, though, that change the picture.
Seek urgent medical help if you experience severe abdominal pain that does not ease, especially if it radiates to your back or is accompanied by vomiting. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis, an uncommon but serious condition. Pancreatitis does not feel like constipation; it is a different quality of pain, persistent and often severe. If in doubt, call NHS 111 or go to A&E.
Similarly, if you have not had a bowel movement for more than a week, or if you notice blood, get advice the same day. Prolonged constipation can occasionally lead to complications that are much easier to treat early. You can also read about the broader side-effect profile of Mounjaro to understand where constipation fits alongside other GI symptoms like nausea, which we cover separately on the Mounjaro nausea page.
Side effects like constipation are a routine part of the clinical conversation, not an embarrassing admission. If what you are experiencing feels unmanageable, or if you are considering slowing your titration to give your gut more time, your prescriber is the right person to talk to, not a forum. Adjusting pace is a clinically led decision.
At nume, every repeat order goes through a fresh clinical review before anything is dispensed. That means your prescriber sees how you are getting on, not just whether your BMI has changed. If you find yourself constipated on Mounjaro and it is affecting how you are tolerating treatment, that is relevant clinical information your prescriber needs to know. You can reach the aftercare team seven days a week via the contact page.
If you are not yet on treatment and side effects like this are part of what you are weighing up, you can check your eligibility through a free consultation, our prescribers go through suitability and the likely side-effect picture as a normal part of the process. You can also read more about Mounjaro as a treatment or explore why constipation on tirzepatide can be more stubborn than expected before you decide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.